BTMD News

Biote Reports Second Quarter 2025 Financial Results

BTMD

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the second quarter ended June 30, 2025. “Consistent with our action plan to drive structural and cultural change, Biote initiated an organizational restructuring in early May designed to strengthen our business and position us for increased and sustainable profitable

August 6, 2025Earnings
Read more →

Biote Names Rich Barrera to Board of Directors

BTMD

IRVING, Texas--(BUSINESS WIRE)--biote Corp.(NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that its Board of Directors has elected Rich Barrera to the Board, effective immediately. “We are pleased to welcome Rich Barrera to Biote’s Board of Directors,” said Marc Beer, Executive Chairman of Biote. “Rich has a distinguished background as an investment professional, founding R

Biote Affirms FY2025 Sales Guidance of $202.00M-$208.00M vs $205.31M Est

BTMD

May 7, 2025
Read more →

Biote Q1 EPS $0.37 Beats $0.07 Estimate, Sales $48.99M Beat $46.99M Estimate

BTMD

May 7, 2025
Read more →

Biote Says Several Members Of Its Board, Along With CEO Bret Christensen, Made Open Market Purchases Of Aggregate 260,000 Shares

BTMD

March 18, 2025
Read more →

Biote Sees FY25 Revenue $202M-$208M Vs $227.18M Est.; Adj. EBITDA $59M-$64M

BTMD

March 13, 2025
Read more →

Biote Q4 2024 GAAP EPS $0.10, Inline, Sales $49.834M Miss $51.245M Estimate

BTMD

March 13, 2025
Read more →

Craig-Hallum Maintains Buy on Biote, Lowers Price Target to $8

BTMD

March 13, 2025
Read more →

Watching Biote; Shares Spike Lower As J Capital Issues Report On Company, Announcing It Has Taken A Short Position

BTMD

May 20, 2024
Read more →